7.4.4 Next-generation agonists The development of dual GLP-1/GIP receptor agonists (e.g., tirzepatide) and novel blood-brain barrier-penetrant formulations may offer superior neuroprotective efficacy by more potently engaging central receptors or providing a broader spectrum of action (Ghaleb et al., 2025)
While more studies are needed to fully understand the implications, there is growing interest in exploring the impact of semaglutide on neurodegenerative conditions, such as Alzheimers disease
Sherry, N
Learn more about men's weight loss care Chronic Disease and Metabolic Health Support Excess weight is closely tied to conditions such as prediabetes, type 2 diabetes, high blood pressure, high cholesterol, fatty liver, and a higher risk of sleep apnea
| Thrillist
Comparative effectiveness research with established therapies would help determine the relative benefits and risks of these peptides compared to current standard treatments and would inform evidence-based treatment decisions